Membership
Tour
Register
Log in
Gilles Buchwalter
Follow
Person
Cambridge, MA, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Combination therapies comprising apremilast and Tyk2 inhibitors
Patent number
11,357,775
Issue date
Jun 14, 2022
Celgene Corporation
Peter Henry Schafer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Patents Applications
last 30 patents
Information
Patent Application
COMBINATION THERAPIES COMPRISING APREMILAST AND TYK2 INHIBITORS
Publication number
20250235450
Publication date
Jul 24, 2025
Celgene Corporation
Peter Henry Schafer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS
Publication number
20250230251
Publication date
Jul 17, 2025
Bristol-Myers Squibb Company
Lin Hui SU
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMBINATION THERAPIES COMPRISING APREMILAST AND TYK2 INHIBITORS
Publication number
20220339151
Publication date
Oct 27, 2022
Celgene Corporation
Peter Henry Schafer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
COMBINATION THERAPIES COMPRISING APREMILAST AND TYK2 INHIBITORS
Publication number
20200345731
Publication date
Nov 5, 2020
Celgene Corporation
Peter Henry Schafer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE